TRENDING :  Market Movers  |  Top 50   SPY (-0.31%)    TSLA (-6.03%)    BYND (0.17%)    BTCUSD (%)    FTNT (-0.73%)    ELTK (-3.03%)    CANF (-7.48%)    ARQL (0.56%)    MCHP (-0.15%)    ONCS (-32.5%)    VXX (-0.95%)    IP (-1.4%)    INTC (-1.04%)    GTN (-1.44%)    GLW (0.1%)    ANY (-1.05%)    AMZN (0.12%)    AMPH (-1.4%)    ACAD (-1.57%)    ECOR (-13.74%)    DIS (-0.18%)    DFRG (1.48%)    CMG (-1.26%)    CGC (2.29%)    CCCL (-2.81%)

 JNCE - Jounce Therapeutics

$5.07 [0][0%]

Next Earnings

8/8/2019

BMO

Recommend
Trade Idea »


OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $JNCE

Service NameTrader% Success
Arbitrage Trade AnalyticsRoyce Wells72.00 %Subscribe
Tech and Biotech CatalystsMichael43.00 %Subscribe

TRENDING ARTICLES


Jounce Therapeutics, Inc. (JNCE) Reports Q1 Loss, Misses Revenue Estimates

05/08/19
Jounce Therapeutics Inc JNCE came out with a quarterly loss of 0 38 per share versus the Zacks Consensus Estimate of a loss of 0 31 This compares to loss of 0 40 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings

Will Jounce Therapeutics, Inc. (JNCE) Report Negative Q1 Earnings? What You Should Know

05/01/19
Wall Street expects a year over year increase in earnings on higher revenues when Jounce Therapeutics Inc JNCE reports results for the quarter ended March 2019 While this widely known consensus outlook is important in gauging the company s earnings picture a powerful factor that could